Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA ( tionwhich is generally recognised as ...)

Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA

tion, which is generally recognised as being the most important attribute in the treatment of cancer breakthrough pain. We now look forward to moving this product into Phase III studies."

Notes for Editors:

About Sosei

Sosei Group Corporation is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit www.sosei.com

About AD 923

AD 923 is an optimised, sublingual formulation of the strong opioid analgesic fentanyl. It has been specifically designed to provide rapid onset of analgesia in a device that is easy to use by either the patient or their care giver. An additional benefit is the lockout system that prevents inadvertent overdosing. Sosei has concluded a range of studies that confirm the potential of this novel product.

In June 2006, Sosei entered into an agreement with Mundipharma International Corporation Limited for the development and commercialisation of AD 923 in Europe and other international markets, excluding North America and Japan. Sosei is currently evaluating its commercialisation options for the un-partnered territories.

About Cancer Breakthrough Pain

Cancer breakthrough pain is characterised by temporary exacerbations of moderate to severe pain in cancer patients that "breakthrough" their around-the-clock opioid treatments. Each episode may be spontaneous or incidental to an activity. It is estimated that the condition is prevalent in approximately 60% of cancer pain patients across Europe, the US and Japan, representing a total population size of 2.3 millio
'"/>

Page: 1 2 3
Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:

(Date:11/9/2009)...9 Hologic, Inc. (Hologic...oper, manufacturer and supplier of premium diagnos...s dedicated to serving the healthcare needs of wom...rter and fiscal year ended September 26, 2009. In ...ectors has promoted Robert Cascella to Chief Execu...

(Date:11/9/2009)..., N.J., Nov. 9 Pharmasse... present at the Sixth Annual Lazard Capital Market...ld at the St Regis Hotel in New York City (Novembe... President and Chief Executive Officer, will provi...er 18, 2009 at 3:45 PM (ET). ,, To access a sim...

(Date:11/9/2009)...09 Arena Pharmaceuticals...esults for the third quarter ended September 30, 2...le to common stockholders in the third quarter of ...d to a net loss allocable to common stockholders i...0.76 per share, and a net loss allocable to common...

[0] Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results [0] Pharmasset to Present at Lazard Capital Markets Healthcare Conference [0] Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments

...ublic health, we need to fast-track research and a...if., Oct. 24 On the heels,of a study published th...ing science related to HPV and oral cancer in the ...oundation is urging researchers to,expedite invest...V),vaccinations for males, and the FDA to fast tra...

... EVEREST Patient Registry Presented at TCT 2007; E...t Continues, WASHINGTON, Oct. 24 The vast majori...e percutaneous MitraClip device did not need,mitra... and many benefited,from significantly improved fu...verse remodeling), according to data presented thi...

Other Medicine Technology:The Oral Cancer Foundation Urges HPV Vaccination for Males 2 The Oral Cancer Foundation Urges HPV Vaccination for Males 3 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 2 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 3 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 4 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 5

The Oral Cancer Foundation Urges HPV Vaccination for Males New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation

(Date:11/9/2009)...etary Vilsack, Governor Patrick, and Lieutenant Go...Newswire/ -- In a groundbreaking move for antihung...r) called for all of the state,s hospitals to take...r care. ,, "With 554,000 people in Massachuset...ess conference at UMass Memorial Health Care in Wo...

(Date:11/9/2009)...PRNewswire-Asia-FirstCall/ -- Mindray Medical,Inte...r, manufacturer and,marketer of medical devices wo...nancial results for the third quarter and nine mon...or Operations as of September 30, 2009, -- Thir...n increase of, 3.1% over the third quarter o...

(Date:11/9/2009)...guage, Federal Trade Commission Involvement Need t... Inclusion of a provisi...H.R. 3962) allowing insurance agents to sell healt...s positive, but other issues remain to be addresse...tion of Professional Insurance Agents (PIA). ,,...

(Date:11/9/2009)...re/ -- Tracy Anderson, trainer to Gwyneth Paltrow,...sting two events at her LA studio this week that a...waited Nutritional Meal Plan and Delivery Service,...e and Lifestyle Menu. She will also be teaching a...of cardio and muscle structure work. Both events ...

(Date:11/9/2009)...equally, study finds, , , MONDAY, Nov. ...ing drug Plavix (clopidogrel) works about the same... trials has found. , "After this study, I can s...men with this very important drug," said Dr. Jeffr...s at New York University Langone Medical Center in...

[0] McGovern and Project Bread Launch Hospital Hunger Initiative [0] Mindray Announces Third Quarter 2009 Financial Results [0] PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain [0] Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week [0] No Gender Gap Found for Clot-Busting Drug

... with post traumatic stress disorder (PTSD) have s...f life according to research by Dr. J. Donald Rich...s co-investigators. , The research, published thi...ies just as much to peacekeeping veterans as to co...

...ast-Growth Companies to Quell Your Recession Fears... Nuclear Medicine Professionals, Inc. Ranks No. 46... 1161 on the Inc. 5000 With Three-Year Sales Growt...c.] on its annual ranking of the 5000 fastest-grow...

...Is Needed, Says Editor of "The Oncologist", DURHA...,a study supporting the use of computed tomography...in smokers and other people at risk, the,Editor-in... ), " ... the results of this key lung cancer pr...

... 1, 2008 is a landmark,day in Tennessee history. T...erm Care Partnership that rewards Tennesseans for ...y. By encouraging the purchase of long-term,care i...te Medicaid budget saves money., Tennessee joins ...

..., Inc.,(Nasdaq: THRM ), a leader in non-invasive ... announced that it will present at the 2008 Maxim ...n is scheduled for 10:00 a.m.,Eastern Time on Tues...inancial results., Attendance at the conference i...

... - Share Exchange Offer to the Holders of the Foll... ISIN: US4781601046 - Symbol: JNJ, The K&N Value ...ities,named above for every 1 Johnson & Johnson sh...th November,2008., K&N Value Select Corp. reserve...

Other Medicine News:Health News:Whether combat or peacekeeping, PTSD impacts veterans' well-being 2 Health News:America's 5000 Fastest-Growing Private Companies Revealed 2 Health News:New Questions Raised About Lung Cancer Screening 2 Health News:New Questions Raised About Lung Cancer Screening 3 Health News:Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement 2

Whether combat or peacekeeping, PTSD impacts veterans' well-being America's 5000 Fastest-Growing Private Companies Revealed New Questions Raised About Lung Cancer Screening Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement Thermage, Inc. to Present at the Maxim Group Growth Conference Johnson & Johnson Share Exchange Offer

...system from Del Mar Reynolds Medical. Available as...ergometer, PC, Cart, isolation transformer and a n...ct patient interface module that is used for resti... the CardioCollect as the patient interface module...

...diagnosis, the fully featured CH2000 Stress Test S...t measures T-wave alternans at the microvolt level...ol facility, this combines with the WAVESTAR ECG f... outstanding and noise-free ECG recordings with mi...

...ess system, the Quest, combines innovative touchsc...ilities. Combined with a 15" color monitor, users ... to program or select specific functions. Quest ev...ghting the step usually taken next. No more search...

...or makes refracting easier for you and your patien...rts in any order you wish, freeing you to conduct ...ng one button each time you want to move to the ne...random access gives you the option of performing a...

Medicine Products:

CardioDirect12-S Cambridge Heart CH2000 Stress-Test System Quest Exercise Stress System CP-690E Automated Projector

( tionwhich is generally recognised as ...)Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA,Health